Inflammatory Bowel Disease (IBD) is a chronic condition where the patient experiences reoccurring inflammation of the gastrointestinal tract, most often centered around the large intestine.
As it is a chronic condition with a relatively high prevalence, the condition gets a lot of attention from academic research groups as well as pharma companies working on solutions to increase the quality of life of these patients.